3Krupa Shankar DS,Ramnane M,Rajouria EA. Etiological approach to chronic urticaria[J].{H}Indian Journal of Dermatology,2010.33-38. 被引量：1
4Najib U,Bajwa ZH,Ostm MG,el a1. A retrospective review of clini-cal presentation,thyroid autoimmunity,laboratory characteristics,an d therapies used in patients with chronic idiopathic urticaria[J].{H}Annals of Allergy Asthma and Immunology,2009.496-501. 被引量：1
5Gispert J,Antonijoan R,Barbanoj M,et a1. Efficacy of ebastine,ceti-rizine,and loratadine in Histamine cutaneous challenges[J].{H}Annals of Allergy Asthma and Immunology,2002,(03):259-364. 被引量：1
6Shon JH,Yeo CW,Liu KH,et a1. Itraeonazole and rifam pin alter significantly the disposition and an tihistamine efect of ebastine and its metabolites in healthy participants[J].J Clin Pharmacal,2010.195-204. 被引量：1
3Nijmeijer S, Leurs R, Vischer H F. Constitutive activity of the hista- mine H( 1 ) receptor[ J ]. Methods Enzymol,2010,484: 127 - 147. 被引量：1
4Mizuguchi H, Ono S, Hattori M, et al. Inverse agonistic activity of anti- histamines and suppression of histamine Hi receptor gene expression [J]. J Pharmacol Sci,2012,118(1) : 117 -21. 被引量：1
5Tanizaki H, Ikoma A, Fukuoka M, et al. Effects of bepotastine and fexofenadine on histamine -induced flare, wheal and itch[ J]. Int Arch Allergy Immunol,2012,158 (2) : 191 - 195. 被引量：1
6Scaglione F. Safety profile of bilastine: 2rid generation H1 - antihista- mines[J]. Eur Rev Med Pharmacol Sci,2012,16(14) : 1999 -2005. 被引量：1
